Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensitizing Potential of Pefcalcitol (M518101) in Healthy Volunteers
NCT02256930Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of pefcalcitol in plaque psoriasis (4 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Inflammatory skin response score at 21 days. Started Sep 2014; status: completed.
02
Drugs
pefcalcitol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02256930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256930.